Melocox (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which limits the production of prostaglandins that mediate inflammation, pain, and fever. By sparing COX‑1, it aims to maintain gastric protection while providing anti‑inflammatory effects.

The specific dose of Melocox is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual response. Dosage adjustments may be required for renal or hepatic impairment, and the prescriber will provide the appropriate regimen.

Safety data for meloxicam in pregnancy are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. It is excreted in breast milk, so breastfeeding mothers should consult their physician before using Melocox.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melocox (meloxicam) offers relatively selective COX‑2 inhibition, which may reduce gastrointestinal side effects compared with non‑selective NSAIDs like ibuprofen or naproxen. However, cardiovascular and renal risks remain, and choice of therapy should be individualized by the prescriber.

Melocox should be stored at room temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Do not store in humid environments or expose the product to excessive heat.

Melocox is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may lessen gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), liver enzyme elevation, and acute renal failure. Patients should report any unusual symptoms promptly.

Melocox is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulceration, severe heart failure, and those who have had recent coronary artery bypass graft surgery. It should also be avoided in patients taking certain anticoagulants or lithium without close monitoring.